Gul MH, Wardak AB, Waheed A. Navigating a paradigm shift; food and drug administration approved Tarlatamab-dlle redefining the landscape of small cell lung cancer therapy. Int J Sci Rep [Internet]. 2024 Jul. 25 [cited 2025 Nov. 13];10(8):303-4. Available from: https://www.sci-rep.com/index.php/scirep/article/view/1385